After that, we sought to parse out clinical features of patients with high‐risk scores, the high‐risk group displayed a strong tendency toward advanced age, poor cytogenetic risk, and RUNX1 mutation, all of which were indicative of a poor prognosis in AML.16, 21. Here, RUNX1 is linked to acute myeloid leukemia.